Press "Enter" to skip to content

FDA gives patients hope after approving brain cancer drug with Duke ties

FDA approves new brain cancer drug linked to Duke research, trial The FDA approved vorasidenib earlier this month for adult and pediatric patients 12 and older with Grade2 astrocytoma or oligodendroglioma.
Source: WRAL News

Be First to Comment

    Leave a Reply